NeoImmune Tech

NeoImmuneTech receives orphan drug status for NT-I7 to treat ARS
Pharmaceutical Business Review
Tue, 11/21/23 - 11:59 am
NeoImmune Tech
FDA
NT-I7
acute radiation syndrome
orphan drugs
NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
CP Wire
Wed, 05/2/18 - 09:58 am
NeoImmune Tech
Genexine
Roche
R&D
melanoma
Merkel cell carcinoma
cutaneous squamous cell carcinoma
NeoImmuneTech and Roche Collaborate in Clinical Trial of HyLeukin-7 in Combination with a PD-L1 Checkpoint Inhibitor in Advanced High-Risk Skin Cancers
Tue, 05/1/18 - 09:16 pm
NeoImmune Tech
Genexine
Roche
HyLeukin-7
checkpoint inhibitors
melanoma